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SUMIVIARY
Decorin is ubiquitously distributed in the extraceUular matrix of mammals and a member of the
proteoglycan family characterized by a core protein dominated by Leucine Rich Repeat motifs. We
here demonstrate that decorin extracted from bovine tissues under denaturing conditions or
produced in recombinant "native" form by cultured mammalian cells, has a high affinity for Zn '-+.
Binding of Zn '+ to decorin is demonstrated by Zn '+ chelating chromatography and equilibrium
dialyses. The Zn 2+ binding sites are localized to the N-terminal domain of the core protein that
contains 4 Cys residues in the spacing reminiscent of a Zn finger. A recombinant 41 amino acid
long peptide representing the N-terminal domain of decor'in has full Zn 2+ binding activity and binds
two Zn _-+ions with an average Ko of 3x10-TM. Biglycan, a proteoglycan that is structurally closely
related to deCorin contains a similar high affinity Zn _+ binding segment, whereas the structurally
more distantly related proteoglycans, epiphycan and osteoglycin, did not bind Zn 2+ with high
affinity.
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INTRODUCTION
Decorin, a small chondroitin/dermatan sulfate proteoglycan, is found in the extracellular
matrix of a variety of tissues such as skin (1-3), cartilage (4-5), and bone (6-7). This
proteoglycan is composed of a 40 kDa core protein and one glycosaminoglycan chain attached to
a serine residue in the N-terminal part of the protein. The decorin core protein is dominated by a
central region composed often Leucine Rich Repeat units. Each unit contains 21-26 amino acid
residues and is proposed to adopt a characteristic ot-helix/13-sheet folding pattern (8-9). The C-
and N-terminal regions of the core protein are believed to form globular structures stabilized by
disulfide bonds between sets of cysteine residues. Several proteoglycans have core proteins of
similar size and structural organization. These related molecules are considered to form a family
called Small Leucine Rich Proteoglycans (SLRP) (9-10). The family of SLRPs include decorin,
biglycan, and epiphycan, all of which contain chondroitin/dermatan sulfate chains attached to the
N-terminal domain of the core protein and fibromodulin, Iumican, keratocan, PRELP, and
osteoglycin which often have keratan sulfate linked to asparagine residues in the central region of
the core protein. The extraeellular matrix glycoprotein chondroadhefin has a structural
organization similar to the core proteins of the SLRPs but has not been shown to be substituted
with glycosaminoglycan chains (11). The biological importance of the different SLRPs is unclear.
In vitro binding studies have shown that deeorin, biglycan, and fibromodulin can interact with
several types of collagen (12-16) and different SLRPs are believed to be important regulators of
collagen fibrillogenesis. In support of this hypothesis, a decorin deficient mouse was found to
have fragile skin with an abnormal organization of collagen fibers (17). The phenotype appears
to be largely restricted to the skin, perhaps suggesting that other SLRPs have similar functions
and may fulfill this role in other coUagenous tissues. In fact, a kmaican deficient mouse also
exhibited abnormal collagen fibers both in the skin and in the cornea (18).
Decorin may also affect the production of other extracellular matrix components by
regulating the activity of TGF-B (19-20). Additionally, decorin can modulate the interactions of
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matrix molecules uchasfibronectinwith cells(21-23). Theseobservations uggestthat decorin
and perhaps other SLRPs regulateat several levels the production and assembly of the
extracellularmatrixandhencetheremodelingof connectivetissue.
Zinc, a divalentcation,is one of the essentialtrace elementsfor eukaryoticorganisms.
Zinc ions plays- a key role in biological processes by being directly involved in enzyme catalysis
or by binding to specific sites in a protein to stabilize the conformations which are of importance
to the function of the protein (24-25). In the extracellular matrix, zinc is required for the activity
of matrix metalloproteases which are responsible for the degradation of structural extracellular
matrix components (26). Breakdown and remodeling of the .ECM occur in normal embryo
development, wound healing, and many pathological processes such as cancer, arthritis, and
osteoporosis (26-27). Structural extracellular matrix molecules such as laminin (29), link protein
(30), nidogen (31), and COMP (32) have been shown to bind zinc ions. The Zn 2+ binding sites
have been located to subdomains of some of these proteins (31,33).
In a previous study, biglyean was shown to self associate in the presenceof zinc ions and
shown to bind Zn 2÷, Ni 2÷, and Cu 2÷ in metal chelate affinity chromatography studies (34).. The
binding affinity and binding domain, however, have not been reported. In this study, we
demonstrate that deeorin is a metalloprotein and binds two zinc ions per core protein with an
average KD of-llaM. The Zn 2+ binding domain is mapped to the N-terminal region in the
decorin core protein and a short (41 amino acid long) peptide is shown to have full Zn 2÷ binding
activity. Furthermore, the Zn 2÷ binding activity of the corresponding segments in the
structurally related core proteins of biglycan, epiphycan, and osteoglycin are analyzed.
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EXPERIMENTAL PROCEDURE
Preparation ofDecorin Proteoglycans Decorin was extracted and purified from bovine skin
under denaturing conditions as described previously (3). Intact recombinant decorin was produced
in HT1080 cells using a vaccinia vii'us based expression system. The recombinant virus construct
contains a segment encoding a N-terminal polyhistidine tag, a Factor Xa cleavage site and the
mature human decorin core protein starting with an Asp residue found at position #31 of the full
length human sequence (35). The polyhistidine tag in the recombinant protein allows for its
efficient purification by Ni 2+ chelating chromatography. The resulting decorin preparation contains
a mixture of proteoglycan and core protein forms. The details of this system have been described
earlier (35-36). For the studies described here, the polyhistidine tag was removed from the
recombinant decorin by digestion with Factor Xa (Pierce, Rockford, IL) followed by reapplieation
of the digestion mixture to a Ni 2÷ charged column. The f'mal product of cleaved recombinant
decorin was collected in the "flow-through" fractions whereas the polyhistidine _ and uncleared
protein were retained on the column.
Recombinant Decorin Core Protein Fragments A series of recombinant decorin core
protein fragments were produced in E. coli. A mouse embryo eDNA library (Clonetech, Palo
Alto, CA) was used as a template along with appropriate primers (Table 1A) to PCR amplify the
decorin eDNA segments. Conditions for PCR were 94" C/7 min, followed by 35 cycles involving
94"C/1 min, 50"C/2 min, and 72"C/3 rain. The individual segments were purified, cleaved with
appropriate restriction enzymes and ligated into the pMAI_,-p2 expression vector (New England
Biolabs, Beverly, MA) which contain a segment encoding the maltose binding protein (MBP) at
the 5' end of the expression cassette. The eDNA fragments (MD and MD3) generated with the
DCNR2 primer which contains a EcoRI site at 3' end, were f'trst subcloned into the pBluscript
SK+/- vector (Stratagene, La IoUa, CA) through BamHI and EcoRI sites. Subsequently, the
MD/pBluscript and MD3/pBhseript constructs were digested with BamHI and HindlH and then
ligated into the pMAL-p2 expression vector. To produce MBP as a control protein without any
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segmentof decorinfusedto it, a modifiedpMAL-p2 vectorcontaininga stop codon and a short
polylinker was constructed. The complementary oligonucleotides, MBPF (5'-
gatcctgatctagagcatgcctgca-3')andMBPR (5'-ggcatgctctagatcag-3')were obtainedand allowedto
form a doublestrandedoligonucleotidecontainingacohesiveBamHIsiteatthe5'-end followed by
astopcodon,XbaI, SphI.andPstIsites. The originalpMAL-p2 vectordigestedwith BamHI and
PstI was thenligatedwith thatdoublestrandedoligonucleotide.The newly introducedSphI site
which is not presentin theoriginalpMAL-p2 vectorwas used in a restrictionenzymedigestion
screento isolateclonescarryingtheengineeredplasmid. The sequencesof all decorin/pMAL-p2
constructs isolatedfrom selectedcloneswere confi.rmedby DNA sequencing(Departmentof
VeterinaryPathobiology,Texas A&M University, College Station, TX').
Expression and Purification of Recombinant Decorin Core Protein Subdomains
Previously, a method developed for the production of full length bovine decorin core protein using
a pMAL expression system has been reported (37). This procedure involved solubilization and
refolding of protein recovered from inclusion bodies. In our case, we obtained significant amounts
of soluble recombinant protein from all constructs and we did not attempt to solubilize protein from
inclusion bodies.
The expression vector constructs were used to transform the E. coli. strain TB 1. The
procedure adopted for the expression and purification of the MBP-decorin fusion protein was
based on the manual provided by New England Biolabs. In brief, a flask containing 950 ml of
Lennox LB (Sigma, St. Louis, MO) was inoculated with 50 ml of a TB 1/MBP-decorin overnight
culture and grown on a platform shaker for 3-4 h at 37"C when the culture reached an OI)600 of
0.6-0.8. Expression of fusion protein was induced by adding IPTG (Gibco BRL, Gaithersburg,
MD) to the culture at a final concentration of 0.2mM and incubation was continued for another 3 h.
The bacterial cells were harvested by centrifugation at 4500 rpm for 20 rain. The cell pellet was
resuspended in Buffer A (20mM 'Iris, 200mM NaC1, pH = 8.0) to a f'mal volume of 10 ml/L of
culture and frozen at -80"C for a minimum of 18 h. To purify the fusion proteins, the cells were
thawed and lysed using a french press. The lysate was cleared by centrifugation at 40,000 rpm for
20 rain andthesupernatantwasappliedto a5 ml amyloseaffinity column(New England Biolabs,
Beverly, MA) equilibrated with 25 rnl of Buffer A. The column was washed with 50 ml of Buffer
A and the MBP-decorin fusion protein was eluted by Buffer A containing 10 mM maltose. The
purity of the fusion protein was >70% as judged by SDS-PAGE and the yield was 5-10 mg/L of
culture. To improve the purity of fusion proteins, an additional purification step was required. Ion
exchange chromatography was used for further purifyingMBP-MI)2 and MBP-MD3 protein. The
proteins were dialyzed into a buffer composed of 25 mM NaC1, 20 mM Tris, pH = 8.0 and applied
to a column of Q-sepharose (Pharmacia Biotech, Piscataway, NJ) equilibrated with the same
buffer. The protein was subsequently eluted with a NaCI gradient (25-500 mM) in 20 mM Tris,
pH = 8.0. Metal ion chelating chromatography on iminodiacetic acid immobilized Sepharose 6B
2+
resin (Sigma, St. Louis, MO) charged with Zn was used to further purify MBP-MD, MBP-MD1,
and MBP-MD4. The procedure used for charging the column with Zn 2÷ ions is described in the
following section. The purified recombinant proteins were analyzed on SDS-PAGE and Western
blot using two polyclonal antibodies that were raised against synthetic peptides corresponding to
the amino acid residues 31-47 and 309-326 of the mouse decorin core proteins respectively
(Manuscript in preparation). The protein concentrations were determined based on the absorbance
at A_ and the calculated molar extinction coefficient of the different protein constructs (38).
Production and Purification of a N-terminal Decorin Peptide (MD4). To produce large
quantity of MD4 peptide, we used a pGEX-2T expression vector (Pharmacia, Piscataway, NJ').
This MD4/pGEX-2T construct encodes glutathione S-transferase (GST) followed a thrombin
cleavage site and the MD4 fragment. The eDNA fragment encoding MD4 was obtained by PCR
using the mouse embryo eDNA library and primers DCNF9 and DCNR19 as described above
(Table 1A). The resulting PCR fragment was cleaved by BamHI and PstI, purified, and subcloned
into pBluscript. The isolated MD4/pBluscript plasmid was digested with BamH/and EcoRI and
ligated into the pGEX-2T expression vector. The recombinant MD4/pGEX-2T plasmid was then
transformed into the E. coli. strain, BL-21 (Stratagene, La J'olla, CA). An isolate clone containing
the MD4/pGEX-2T plasmid was used after the plasmid had been analyzed by restriction enzyme
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digestionandsequencing.TOexpresstheGST-MD4 fusion protein,flaskscontaining950 ml of
LennoxLB wereinoculatedwith 15ml of a BL21/GST-MD4overnightcultureandincubatedfor
3-4 h whentheculturereachedan A60o of 0.4-0.5. Recombinant protein expression was induced
by adding IPTG to the culture at a final concentration of 0.2 raM. Bacterial cells were harvested 3 h
later by centrifugation at 4'500 rpm for 20 min. The cell pellet was resuspended in PBS (8.4 mM
Na2HPO _, 1.9 mM NaH2PO4, 150 mM NaCI pH = 7.4), supplemented with 5 mM EDTA and
adjusting the pH = 7.5 to a final volume of i0 m//L of culture and frozen at -80"C for a minimum
of 18 h. The cells were thawed and lysed using a french press. One ml of 10% Triton X-100
(Sigma, St. Louis, MO) was added to the cell lysate and mixed until homogeneous. The cell
homogenate was centrifuged and filtered through a 0.45p membrane to remove cell debris.
The GST-M'D4 fusion protein present in the filtered supematant was purified by affinity
chromatography on a 10 ml column of Glutathione-agarose (Sigma, St. Louis, MO) equilibrated
with 50 ml of Buffer B (PBS with 1 mM EDTA, pH = 7.5). The column was washed with 75 mI
of Buffer B and the GST-MI)4 protein was eluted from the column with 20 ml Buffer C (50 mM
Tris, 10 mM glutathione, pH = 7.5). The purity of GST-MD4 in the eluate was >90%, as judged
by SDS-PAGE and the yield was 25-30 mg/L of culture.
To isolate the MD4 pepfide the fusion protein was cleaved with thrombin. The pH and the
concentration of NaC1 of the eluant containing GST-MI)4 was adjusted to pH = 8.3 [NaC1] = 0.15
M using 1 M NaOH and 3 M NaCI stock solutions. Bovine thrombin (Sigma, St. Louis, MO) was
added to give a 1/40 (w/w) enzyme/substrate ratio. The digestion was allowed to proceed
overnight at room temperature. Subsequently, l]-mercaptoethanol was added to the incubation
mixture to a final concentration of 1% (v/v) and the solution was adjusted to pH = 9.5 by addition
of 1 M NaOH. The solution was incubated at 37"C for 30 rnin and filtered through a 0.45p
membrane to remove any particulate material. The MD4 peptide was purified on a Waters 25x200
mm RCM semi-preparative C18 HPLC column and eluted with a gradient of 28% to 36% solvent
B (95o/0 Acetonitrile, 5% H20, 0.1% TFA) in solvent A (95% H20, 5% Acetonitrile, 0.1% TFA)
over 10 min at a flow rate of 25 ml rain "l.
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The purity of the peptide was monitored by running a thi-ee layer Tricine-SDS-PAGE gel
consisting of a 15% acrylamid slab, 10% acrylamidspacer, and a 3.5% acrylamid stacker (39).
The identity of the peptide was conf'a'med by Matrix Assisted Laser Desorption Ionization-mass
spectroscopy (MALDI-MS) (The Center for Analytical Chemistry, University of Texas in
Houston, Houston, TX)..'
Biglycan Preparations Biglycan isolated from bovine articular cartilage was extracted and
purified under denaturing conditions as previously described (3). Recombinant biglycan
containing a N-terminal polyhistidine tag was produced in HT1080 cells using the vaccinia virus
expression system as described (36). The polyhistidine tag was removed and the recombinant
proteoglycan was re-isolated as described above. The preparation of recombinant biglycan contain
a mixture of proteoglycan and core protein forms (36). The N-terminal segment of the biglycan
core protein was produced as a recombinant MBP fusion protein in E. coll. The encoded fusion
protein MBP-MBGN-N is composed of the maltose binding protein followed by a biglycan
peptide, corresponding to amino acid residue 38 to 77. The primers BGNFI.1 and BGNR13
(Table 1A) and the mouse embryo eDNA library were used to PCR amplify an appropriate eDNA
fragment. The resulting PCR product was cleaved, purified, and ligated into the pMAL-p2 vector.
Protein expression and purification protocols were the same as those described above in the
preparation of MBP-decorin fusion proteins.
Dialysis of the Protein In preparation for Zn 2+ binding experiments, all proteins were
dialyzed against Buffer D (20 mM Tris-HC1, 150 mM NaC1, pH -- 7.0) supplemented with 5 mM
EDTA (Sigma, St. Louis, MO) to remove possibly contaminating divalent metal ions and
subsequently dialyzed against Buffer D (without EDTA) with three changes. Buffer D was shown
to contain less than 5x108 M Zn 2÷ions as analyzed by 4-(2-pyfidylazo) resoreinol (PAR) (Sigma,
St. Louis, MO) complex formation (40-41).
Zn2+-Chelating Affinity Column Chromatography A resin composed of iminodiacetic acid
immobilized Sepharose 6B (Sigma, St. Louis, MO) was charged with ten volumes of 2 mg/ml
ZnCI2 (Sigma, St. Louis, MO) in dei0nized water. The resin was then washed with five volumes
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of Buffer E (20 mM Tris-HCl, 150 mM NaC1, pH = 8). The charged Sepharose 6B was packed
on top of equal amount of uncharged iminodiacetic acid Sepharose 6B that has been pre-
equilibrated in Buffer E. The purpose of having the uncharged resin on the bottom of the column
is to trap zinc ions released from the charged resin during the experiment. The dialyzed test sample
was applied to the column. The column was washed with excess amount of Buffer E and the
bound protein was eluted by Buffer F in which the pH of Buffer E was titered to 4.0 by addition of
glacial acetic acid.
Zn 2+ Equilibrium Dialysis The equilibrium dialysis experiments were carried out in a
double acrylic microdialysis module (Hoffer, San Francisco, CA). A dialysis membrane was
assembled in between two modules to separateeach of the eight chambers into two compartments.
The molecular weight cut-off of the dialysis membrane was chosen depending upon the molecular
size of the test protein. The 12,000-14,000 Da cut-off membrane (Hoffer, San Francisco, CA)
was used for the proteoglycan preparations and the MBP fusion proteins. The 2,000 Da cut-off
membrane (Spectra/Pro, Spectrum Medical Industries, Inc, Houston, TX) was used for the MD4
peptide. Aliquots of 150 gl test protein in Buffer D were added to the inner compartments. The
same volume of Buffer D containing increasing concentrations of ZnC12 (0, 2, 4, 8, 16, 24, 32,
and 40 gM) was added to the outer compartments. The assembled modules were fitted on a
rotating axis anti incubated at 4°C for at least 40 h to reach equilibrium.
After incubation, the concentration of Zn 2÷ in the outer compartments was determined using
the metallochromic indicator PAR (41). An aliquot of 120 I.tl from each outer compartment was
added to glass tubes containing 2.4 i.tI of a 5 mM PAR. The components were mixed and
2+
incubated for 30 rain at room temperature to allow the red PAR-Zn complex to form. The
absorbance at As00 from each sample was determined using a DU-70 spectrophotometer (Beckman,
Fullerton, CA). A standard curve of ZnCI2 (0-40 jaM') in Buffer D was generated which showed a
linear relationship by plotting A_ versus the increasing concentration of Zn 2÷. The concentration
of free Zn _÷ in solution from each outer compartment was determined by inserting the observed
absorbance into the standard curve equation.
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The concentration of Zn 2÷bound to protein was determined using equation (A):
[Zn2+]rota = 2[Zn2+]t_ + [znz+]_u.,t (A)
[Zn2+]Tot,_is the total concentration of Zn z+ added to the outside compamnent of the equilibrium
dialysis chamber at the beginning of the experiment. The [Zn2+]r_ term is multiplied by a factor of
2 to take into account the dilution oi_[Zn2+].ro,., at equilibrium in the absence of protein.
An equation derived for multiple, independent binding sites (equation B) was used to
analyze the equilibrium binding data (42):
[Zn2+]bou.dltotalprotein = n([Zn2+]f,_/Kn)/(1 + ([Zn2+]f,v.dKo)) 03)
Total protein is the concentration of protein used in the equilibrium dialysis experiment, n is the
number of Zn 2+ molecules binding to each protein molecule, and KD is the observed dissociation
constant for the Zn2+/protein complex. The reported KD± standard error and Zn "-÷binding curves
represent the average of at least three independent experiments.
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RESULTS
Different forms of decorfn bind Zn2+_
We recently reported that a Zn 2+ charged column of iminodiacetate-Sepharose could be
used to separate decorin and epiph'ycan isolated from fetal bovine epiphyseal cartilage (43). In
this study, Zn 2+ chelate affinity chromatography was used to analyze the Zn 2+ binding activity
of different forms of decorin (Fig. 1). Decorin extracted from bovine skin by 4M GdnHCI and
purified under denaturing conditions bound to the Zn 2+ charged column and could be eluted by
Tris-acetate buffer pH = 4 (Fig. 1A). Most of the decorin was retained on the affinity matrix but
detectable amount of material was recovered inthe "pass through" fraction. This "pass through"
material migrated as a SLRP when analyzed by SDS-PAGE but it was not further analyzed.
Recombinant human decorin produced in HT1080 cells using a vaccinia virus based expression
vector and purified under non-denaturing conditions also bound effectively to the Zn 2+ charged
matrix (Fig. 1B). The low molecular weight protein found in "pass through" fractions
presumably represent an impurity. This recombinant decorin appears to have a different protein
conformation compared to the GdnHC1 extracted tissue form which has been denatured (35).
Thus, these results suggest that the Zn 2+ binding property of decorin is not introduced during
extraction or a property exclusively found in denatured forms of the proteoglyean.
Equilibrium dialysis was used to characterize the Zn 2+ -decorin interaction (Fig. 2). The
proteoglycan isolated from bovine skin and the recombinant decorin both could be saturated with
Zn 2+ and bound a maximum of two Zn 2+ ions per decorin molecule with an average Ko of 1.0 -¢-
0.3 I.tM and 3.9 4- 1.8 _tM, respectively.
The Zn 2+ binding activi_ of decorin is located to the core protein.
The recombinant decorin produced in HT1080 cells appears as a mixture of molecular
species including proteoglycans and core proteins without glycosaminoglycan chains. Both the
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proteoglycanand thecoreproteinforms boundto the Zn2+charged column. The proteoglycans
appear as a diffuse band when analyzed by SDS-PAGE, migrating largely between the 68 and 100
K o molecular standards. The core proteins migrate as a sharper band with an apparent molecular
weight of 50 K D (Fig. IB). The observation that als0 the core proteins bound to a Zn 2+ charged
resin suggests that the pri_nary Zn 2+ binding sites in decorin are located in the core protein. This
hypothesis was further examined by analyzing the Zn 2+ binding properties 'of prokaryotic
recombinants. Recombinant mouse decorin core protein produced in E. coli as a fusion protein
where the core protein is linked at its N-terminal to the maltose binding protein (MBP) also
quantitatively bound to the Zn 2÷ charged matrix (Fig. 1C). MBP alone did not bind to the Zn 2+
charged matrix (Fig. 1D), neither did isolated dermatan sulfate or ehondroitin sulfate
polysaccharides (data not shown). Taken together, these results suggest that the core protein
alone, is responsible for the Zn 2+ binding activity ofdeeorin.
The Zn 2+ binding activity is located to the N-terminal domain of the decorin core brotein.
To further locate the domain responsible for the Zn 2+ binding activity in the core protein,
we analyzed recombinant segments of the mouse deeorin core protein produced in E. coli as
fusion proteins linked to the C-terminus of MBP. The different constructs made are shown in
Fig. 3. All the fusion proteins were at least partially soluble when produced as described in the
Methods Section. Affinity chromatography of bacterial lysate on a column of amylose-
Sepharose resulted in a substantial purification of the fusion proteins, although a second
purification step was required to obtain reasonably pure proteins. Analyses of the different
protein preparations by SDS-PAGE under non-reducing (Fig. 4A) or reducing (Fig. 4B)
conditions revealed that when disulfide bonds were disrupted, each preparation contain a major
band that migl-ated as expected based on the deduced molecular weight of the fusion protein. The
MBP-MI) and MBP-MD1 also contained several minor components of lower molecular weight
possibly due to a degradation of the original fusion proteins. In the absence of reducing agent, a
substantial portion of MBP-MD, MBP-MD1, MBP-MD3, and MBP-MD4 occurred in
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aggregatesthat did not penetratethe gel. Furthermore,the MBP-MD4 preparationscontained
two protein forms that penetratedthe gel andmigratedwith apparentmolecularweights of 46
kDa (comparedto themolecularweightof 50.2kDacalculatedfrom thesequenceof MBP-MD4)
and 88 kDa, respectively. The latter possibly representinga dimer. All of these proteins
includedat leastone of the Cyscontaining end domainsof the decorincore protein. The
aggregatesanddimerswere dissociatedupon reduction. MBP-MD2 includesonly the leucine
rich repeatregionwhich doesnot containany Cys residuesand migratesasa singlebandto the
samepositionboth in thepresenceandabsenceof reducingagent.
Chromatographyof the different fusion proteins on a Zn 2+ charged matrix demonstrated
that MBP-MD, MBP-MD1, and MBP-MD4 bound Zn 2+ whereas MBP-MD2, MBP-MD3 did
not bind the metal ions (summarized in Fig. 3). The Zn 2+ binding recombinant proteins all
contained the N-terminal segment of the decorin core protein whereas this segment was not
present in the non-binders. It is noteworthy that MBP-MD4 which only contains 41 amino acid
residues of the N-terminal deeorin domain binds efficiently to the Zn 2+ charged column.
Equilibrium dialyses showed that both MBP-MD and MBP-MD4 could bind Zn 2+ in a
process that exhibits saturation kinetics approaching a maximum of two Zn 2+ ions per protein
(Fig. 5). The average KD for these interactions was 3.0 ± 1.9 gM and 2.4 4- 0.6 ].tM,
respectively. Binding of Zn 2+ to MBP-MD2 and MBP-MD3, respectively, could not be
demonstrated using equiUibrium dialyses (data not shown). These results suggest that the 41
amino acid long N-terminus of decorin retain full zinc binding activity.
Characterization of Zn :+ binding to the MD4 peDtide
The experiments described above suggest that the Zn 2+ binding activity of decorin is
located to a relatively short segment from the N-terminal part of the core protein. To further
analyze the binding ofZn 2+ to this segment, we made a new MD4 containing construct using the
pGEX-2T vector. The resulting recombinant fusion protein is composed of glutathione S-
transferase (GST) followed by a linker and MD4. This fusion protein which is expressed at a
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much higher level comparedto the MBP basedfusion proteins can be purified by affinity
chromatographyon glutathione-Sepharose.The linker regioncontainsa thrombin cleavagesite
andpreliminary experimentsshowedthat thrombinefficiently cleavedthe linker. The released
MD4 peptide, which contains four extra amino acid residues (Gly-Ser-Asn-Gly) at the N-
terminus followed by residue #31-71 of mouse deeorin, was purified by RP-HPLC. The purity
of th e peptide was verified by SDS-PAGE (Fig. 6). The expected size of the peptide was
4878.56 Da as calculated from the aa sequence and the molecular mass of the isolated peptide
was 4878.37 Da as determined by MALDI mass spectroscopy.
The purified MD4 peptide bound to a Zn 2+ charged iminodiacetate-Sepharose column
(data not shown) and equilibrium dialyses experiments showed that the MD4 peptide bound
Zn 2+ ions in a concentration dependent manner that approached a maximum of two Zn 2÷ ions
bound per peptide molecule (Fig. 7). Analyses of the binding data assuming the presence of two
independent Zn 2+ binding sites in the MD4 peptide suggest an average Ko of 0.28 4- 0.03 gM for
these sites. Analyses of the binding data in a Hill plot did not reveal _iny pronounced
cooperativity between the two binding sites.
The Zn 2+ binding activi_ of BigIycan.
The amino acid sequence of the Zn 2+ binding MD4 decorin peptide is partially conserved
in biglyean but less conserved in epiphyean and osteoglyein (Fig. 8). In previous studies, tissue
extracted biglycan from bovine articular cartilage have been shown to form multimers in the
presence of Zn 2+ (34). We therefore examined the Zn 2÷ binding activity of different forms of
biglycan. Binding to a Zn 2+ charged column was demonstrated for biglyean isolated under
denaturing conditions from bovine articular cartilage or produced as a recombinant proteoglycan
in HT1080 cells infected with a recombinant vaccinia virus containing the human biglyean eDNA
(data not shown). Equilibrium dialyses showed that both the tissue extracted and recombinant
proteoglycan bound a maximum of two Zn 2+ ions per molecule with an average KD of 3.3 4- 2.4
IaM and 5.4 4- 1.4 gM, respectively (Fig. 9A and B). The N-terminal segment of mouse biglyean
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correspondedto aminoacid residues#38-77was expressedin E. coli as a recombinant MBP
fusion protein (MBP-MBGN-N') and shown to bind to a Zn 2+ charged column of iminodiacetate-
Sepharose (data not shown). Analyses by equilibrium dialyses showed that MBP-MBGN-N
could bind a maximum of two molecules of Zn 2+ with an average KD of 2.7 4- 1.6 gM (Fig. 9C).
These results suggest that biglycan is also a Zn z+ binding molecule and that the N-terminus of its
core protein has zinc binding activity.
Segments of epiphycan and osteoglycin core proteins containing the N-terminal domains
were expressed as fusion proteins (MBP-MEPN-N and MBP-MOGN-N, respectively),
purified, and analyzed for Zn z+ binding activity. Both fusion proteins bound to the Zn z+ charged
column (data not shown). In equilibrium dialysis experiments, however, the binding affinity of
Zn 2+ to MBP-MEPN-N and MBP-MOGN-N proteins was too weak (KD>10"SM) to be
detected. These results suggest that residues specifically found in decorin and biglycan but not in
epiphycan or osteoglyein are required for forming the high affinity Zn 2+ binding sites.
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DISCUSSION
In this communication, we report that decorin and biglycan are Zn 2+ metaUoproteins.
These macromolecules are capable of binding Zn 2+ regardless of whether they are purified under
denaturing conditions from tissues or are produced and isolated under non-denaturing conditions
from cultured cells infected by recombinant viruses. Furthermore, the ability to bind Zn 2÷ is not
restricted to decorin from one particular specie since we in thi._ study demonstrate a binding of
Zn 2+ to decorin derived from human, mouse or bovine tissue. Decorin and biglycan are members
of a growing family of ECM proteins that exhibit high affinity for Zn 2+. In addition to matrix
metalloproteases, this family includes, laminin' (29), link protein (30), nidogen (31) and, COMP
(32).
The Zn 2+ binding activity of decorin is localized to a segment in the N-terminal part of the
core protein. A GAG attachment site is also located in this region and involve a Ser residue at
position #34 in the mouse decorin sequence. The carbohydrate components of the
proteoglycans, however, are not directly involved in Zn 2+ binding. In fact, a recombinant peptide
corresponding to the decorin N-terminal domain and produced in E. coli has full Zn 2+ binding
activity. The amino acid sequence of this peptide which contains four Cys residues is
reminiscent of a Zn-fmger but the spacing of the Cys residues is different from previously
reported Zn 2+ binding motifs (24-25). This apparently novel Zn 2+ binding sequence must adopt
a conformation that allows the binding of two Zn 2+ ions per peptide. Experiments are currently
underway to determine the structure of this peptide in complex with Zn 2+ ions. Cys residues
appear to be involved in coordinating the Zn 2+ ions since we in preliminary experiments have
shown that reduction and alkylation of the MBP-MD4 protein resulted in loss of Zn 2+ binding
activity. Earlier analyses of tryptie peptides obtained from bovine biglyean showed that the first
and the forth Cys residues in the N-terminal domain are linked through a disulfide bond (44).
This observation leaves the second and third eys residues as potential Zn 2+ coordinators. If in
fact the Cys residues are involved in Zn 2+ binding, this could help explain the different affinities
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weseefor Zn 2+ among the different forms of decorin tested. The isolated MD4 peptide which
was isolated as a homogenous form by RP-HPLC has the highest apparent affinity for Zn 2+.
The Zn 2+ binding MBP fusion proteins all occurred as mixtures of several molecular
forms where some Cys residues appear to be engaged in forming disulfied linked multimers. The
measured Ko's for Zn 2+ binding to these proteins were higher compared to that recorded for the
isolated MD4 peptide. Perhaps Cys residues engaged in coordinating Zn 2+ in the MD4 peptides
are in the multimers involved in disulfide linkages. Alternatively, this observation may suggest
that structures outside the actual binding site may influence the Zn 2+ binding activity of this
domain. Thus the isolated sequence present in the peptide appears to have a higher affinity for
Zn 2+ than when the sequence is part of a larger structure as in an intact core protein or a
proteoglycan. Deeorin contains in addition to a traditional N-terminal signal pepfide that is
removed on secretion, a 13 amino acid long propeptide, which also oi_en has been removed from
the proteoglycan isolated from tissues. The decorin MD4 peptide or the proteoglycan forms
here shown to bind Zn 2+ with a high affinity do not contain the propeptide. It" is unclear if the
presence of a propeptide may affect the Zn 2+ binding to decorin or biglycan.
Recombinant N-terminal segments of epiphycan and osteoglycin core protein made as
MBP fusions, which contain sequences similar to the Zn 2+ binding sequences present in deeorin
and biglycan, also are retained on a Zn 2+ charged iminodiacetate-Sepharose in this study.
However, the affinity of the MBP-fusion proteins for Zn 2+ is too low to measure reliable binding
constants by equilibrium dialyses. In an earlier study, we found that Zn 2+ chelating
chromatography could be used to fractionate tissue extracted epiphycan (which did not bind to
the eolunm) from decorin (which bound to the column). This result is in contrast to the
chromatography data obtained in the current study and could be explained if the full length
epiphycan proteoglycan has a lower affinity for Zn 2+ compared to the recombinant N-terminal
peptide. Such a pattern was established for decorin. In the N-terminal segments of epiphyean
and osteoglycin, the Cys residues are spaced slightly differently than in the Zn 2+ binding
peptides of decorin and biglycan; there are two compared to three amino acid residues between
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the first and secondCys in epiphycan, osteoglycin and decodn/biglycan, respectively. It is
possible but not yet demonstrated that the spacing Of Cys residues determines the Zn 2+ binding
activity of these segments.
The concentration of Zn 2+ in. body fluids such as blood plasma is approximately 15_tM,
which suggests that both decorin and biglycan in vivo occur in complex with Zn 2+. The
significance of this complex is unclear. Decorin and biglyean which are abundant molecules in the
tissues could serve as Zn 2+ storage pools where the metal ions could be released to proteins
which that have a higher affinity for and need Zn 2+ ions for their activity. In addition, Zn 2+ may
stabilize a conformation in the proteoglyean core proteins which are important for their
functions. In fact preliminary results obtained by analyses of the MD4 peptides using circular
dichroism spectroscopy suggest that the conformation of the peptide is altered in the presence of
Zn 2+. This observation is in agreement with that of Liu et al. (34) who found that biglyean had a
tendency to aggregate in the presence of Zn 2+ which could be caused by a conformational change
in the protein induced by Zn 2+ binding. Future studies of the biology of decorin and biglycan
must take into account the fact that these molecules are Zu 2+ metalloproteins.
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ABBREVIATIONS
IThe abbreviations used are: ECM, extracellular matrix; SLRP, small leucine rich proteoglycan;
PRELP, proline-arginin-rich and ledcine-rich repeat protein; TGFB, transform growth factor 13;
COMP, cartilage oligomeric matrix protein; MBP, maltose binding protein; IgrG, isopropylthio-l]-
g_actosidase; GST, glutathione S-transferase; I-IPLC, high pressure liquid chromatography; TFA,
trifluoroacetic acid; MALDI-MS, matrix assisted laser desorption ionization-mass spectroscopy;
EDTA, ethylenediamine tetraacetic acid; PAR, 4-(2-pyridylazo) resoreinol; DTT, dithiothreitol;
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrop._oresis; PBS, phosphate buffered
saline.
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FIGURE LEGENDS
Figure 1 Binding of Zn 2. to different forms of decorin by Zn2*-chelating affinity
column chromatography. Bovine skin decorin proteoglycan 03DCN)(A), recombinant
human decorin proteoglyean (I-IDCN) (B), recombinant maltose binding protein -mouse decorin
core protein fusion (MBP-MD) (C), and maltose binding protein (MBP) (13) were analyzed for
Zn 2÷ binding activity. 0.5 mg protein was applied to 1 ml Zn2÷-charged column. The column was
extensively washed and the protein was subsequently eluted by Tris-acetate buffer at pH = 4.
Fractions of 0.5 ml were collected and monitored by A280. The arrow indicates where the elution
buffer was applied. The samples were also analyzed by SDS-PAGE on 7.5% [(A) and 03)] and
10% [(C) and ('D)] polyaerylamide gels under 'reducing conditions. (S) represents 30 ill of the
starting material; (P) represents fractions 1-5 which were combined, concentrated to dryness, and
resuspend in 30 gl; 03) represents fractions 12-16 which were combined, concentrated to dryness,
and resuspend in 30 gl. The gels were stained with Coomassie Brilliant Blue R-250.
Figure 2 Zn 2+ binding to decorin; equilibrium dialysis. Decorin extracted from fetal
bovine skin 03DC1_ or produced as a recombinant using a vaccinia virus vector (wI-IDCN) were
examined for their Zn 2+ binding activity using equilibrium dialysis. For further details see the
"F.,xperimental Procedure" section. The K v and number of binding sites (n) ± standard error
represents the average of three experiments. The correlation coefficients for the binding curves
were 0.95.
Figure 3 Constructs of decorin core protein fragments. The diagram shows the
recombinant deeorin constructs expressed in E. coli, their molecular weight (Mw), and summarizes
the results of the different fusion protein's ability to bind to a Zn 2+ charged iminodiacetic acid
column.
Figure 4 Analyses of purified recombinant MBP-decorln fusion proteins by SDS-
PAGE. The purified MBP-decorin fusion proteins were loaded in non-reducing sample buffer
(A) and reducing buffer containing 10ram DTI" 03), respectively, on 12% polyacrylamid gels.
The gels were stained with Coomassie Brilliant Blue R-250. The migration of standard proteins of
the indicated Mw is shown in the left panel.
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Figure 5 Analyses of Zn2+.binding to MBP-M]) and 'MBP-MD4by equilibrium
dialysis. The Zn _* binding of MBP-MD and MBP-MD4 was analyzed by equilibrium dialysis as
outlined in the "Experimental Procedure" section. The data shown represents an average of
triplicate experiments. The correlation coefficients of the binding curves were 0.9.
Figure 6 Isolation and' purification of decorin N-terminal pepttde. The decorin N-
terminal peptide MD4 was expressed as a GST-MD4 fusion protein, cleaved by thrombin digestion
and isolated by RP-HPLC, as described in the '`Experimental Pl:ocedure" section_ The purity of
the peptide was analyzed by tricine buffered SDS-PAGE. Lane 1, glutathione agarose purified
GST-MIM fusion protein, lane 2, RP-HPLC purified GST carder after thrombin cleavage, and
lane 3, RP-HPLC purified MD4 peptide. The migration of standard proteins of the indicated Mw
is shown in the left panel. The 8.2 and 6.2 kDa protein markers are the products of CNBr cleaved
fragments from horse heart myoglobin..
Figure 7 Zn 2÷ binding affinity of MD4 peptlde. Equilibrium dialysis was used to analyze
the binding of the isolated MD4 peptide to Zn 2+ as described in the 'T_,xperimental Procedures"
section. Each data point was the average of triplicate experiments. The correlation coefficient was
0.99.
Figure 8 Partial N-terminal amino acid sequence of mouse deeorln, biglycan,
epiphycan, and osteoglycin. The 41 amino acidsequence of.N-terminus of mouse decofin
(MDCN) which has Zn 2÷binding activity is shown and compared to the corresponding sequences
of mouse biglycan (MBGN), epiphyean (MEPN'), and osteoglyein (MOGN). One amino add
space was added in MEPN and MOGN to obtain an alignment of the four eys residues in these
sequences. The numbering of encoding amino acid sequence was based on the protein sequence
deposited in GenBank.
Figure 9 Zn 2÷ binding affinity of different forms of biglycan. The Zn 2+ binding of
biglycan extracted from bovine articular cartilage (BBGN), produced in culture mammalian cells
using a vaccinia virus vector (wI-IBGN), or a N-terminal peptide expressed as a maltose binding
protein fusion (MBP-MBGN-N)were analyzed by equilibrium dialysis as described in the
"Experimental Procedures" section. Each binding curve was plotted from the average of triplicate
experiments. The correlation coefficients were 0.93;
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